Comprehensive analysis of TCR repertoire of COVID-19 patients in different infected stage

Guangyu Wang1, Yongsi Wang2, Shaofeng Jiang3

  • 1Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin, 541199, China.

Genes & Genomics
|May 14, 2022
PubMed

Insights

The T cell receptor (TCR) repertoire in COVID-19 patients shows significant differences, including reduced diversity and altered gene usage. These TCR changes can accurately distinguish patients from healthy individuals, aiding diagnosis.

Area of Science:

  • Immunology
  • Virology
  • Genomics

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, presents a significant global health challenge.
  • Understanding the immune response is crucial for managing the disease.

Purpose of the Study:

  • To comprehensively analyze the T cell receptor (TCR) repertoire in COVID-19 patients.
  • To identify TCR sequences associated with SARS-CoV-2 infection and disease progression.

Main Methods:

  • Analysis of TCR repertoires in peripheral blood mononuclear cells (PBMCs) from COVID-19 patients at different disease stages (baseline, acute, convalescent).
  • Utilized ImmunoSEQ technology for high-throughput TCR sequencing.
  • Identified TCR beta-chain (TCRβ) complementary-determining region 3 (CDR3) features and gene usage.

Main Results:

  • COVID-19 patients exhibited distinct TCRβ CDR3 repertoire features compared to controls, including decreased diversity, abnormal CDR3 length, altered TRBV/J gene usage, and increased sequence overlap.
  • Identified specific TCRβ clones associated with COVID-19, with abundance correlating to disease progression.
  • These disease-associated TCRβ clones demonstrated high accuracy in distinguishing COVID-19 patients from healthy individuals.

Conclusions:

  • The study provides a detailed understanding of the TCR repertoire alterations in COVID-19.
  • These findings lay the groundwork for improved diagnostic and therapeutic strategies for COVID-19 patients.
Abstract